Skip to main content

GOLDMAN SACHS GROUP INC

Position in HOWL — Werewolf Therapeutics, Inc.

CIK 886982 NEW YORK, NY

Position in HOWL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$7,208
-$24,667 QoQ
Shares Held
20,023
-47.7% QoQ
Ownership
0.041%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#26
of 45 holders
Holding Since
Jun 2021
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in HOWL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,040,380,016 across 360 Biotechnology names. HOWL ranks #349 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in HOWL

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $7,208 20,023
2026-03-31 $31,875 38,266
2025-12-31 $21,602 34,073
2025-09-30 $118,871 60,341
2025-06-30 $247,911 227,442
2025-03-31 $108,849 111,985
2024-12-31 $209,908 141,830
2024-09-30 $244,098 115,141
2024-06-30 $127,097 52,089
2024-03-31 $1,119,705 172,794
2022-06-30 $44,920 10,983
2022-03-31 $51,282 11,655
2021-12-31 $120,052 10,080
2021-06-30 $652,866 37,435